ÿþ<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><html xmlns="http://www.w3.org/1999/xhtml"><head><title>Comment Summary</title><link media="all" href="css/Export.css" type="text/css" rel="stylesheet" /></head><body style="margin-left: 15px; margin-right: 15px; margin-top: 15px"><a onfocus="blur();" href="SurveySummary.html" class="NormBtn" />&nbsp;<< Back to Summary&nbsp;</a><div style="margin-top: 15px"><table class="rsltsmry" cellspacing="1" cellpadding="0" border="0"><thead><tr><th class="hdr" colspan="3">Prior to the results of the Vytorin-ENHANCE study being made public in January 2008, which was your preferred cholesterol-lowering drug?</th></tr></thead><thead><tr><th class="hdr dflt">#</th><th class="hdr dflt">Response Date</th><th class="hdr dflt" style="width:99%;">Other (please specify)</th></tr></thead><tbody><tr><td>1.</td><td style="white-space:nowrap;">4/22/2008 10:03:00 PM</td><td>Simvastatin</td></tr><tr><td>2.</td><td style="white-space:nowrap;">4/22/2008 10:07:00 PM</td><td>Preference depends on many factors. No single choice.</td></tr><tr><td>3.</td><td style="white-space:nowrap;">4/23/2008 2:11:00 AM</td><td>VYTORIN IF NEEDED 60+MG/DL DROP</td></tr><tr><td>4.</td><td style="white-space:nowrap;">4/23/2008 2:58:00 PM</td><td>gemfibrozil, tricor</td></tr><tr><td>5.</td><td style="white-space:nowrap;">4/23/2008 6:56:00 PM</td><td>No preference -tailored to individual</td></tr><tr><td>6.</td><td style="white-space:nowrap;">5/2/2008 1:52:00 AM</td><td>I use them all and have no one strong preference</td></tr></tbody></table></div></body></html>